Roger Bate | 19 Jul 2008 | Washington Post
The Justice Department and the Food and Drug Administration are looking into whether Ranbaxy Laboratories, one of the world's biggest makers of generic drugs, manufactured substandard HIV drugs that were administered to thousands of poor Africans under a contract with the President's Emergency Plan for AIDS Relief, the Wall Street Journal reported this week. But this type of tragedy has already affected American consumers.
None | 08 Jul 2008 | Africa Fighting Malaria
AFM welcomes the work that the UK's All Party Parliamentary Group on Malaria (APPMG) does to increase the profile of the disease in the UK and improve malaria control and treatment. The APPMG's July Statement, "Focus on Delivery to Achieve Sustained Impact" rightly recognizes the problems of many malarial countries as "weak health systems and limited numbers of skilled health workers." However AFM is concerned that the Responses that the APPMG has detailed will be insufficient to tackle these problems.
None | 01 Jul 2008 | Africa Fighting Malaria
Media coverage of malaria treatment focuses mostly on public sector drug delivery and new formulations of drugs under development. However, most anti-malarial drugs are obtained in the private sector, and few of the widely discussed drugs are actually bought by most Africans. This bulletin is the first in a series of papers discussing some of the less documented issues related to access of anti-malarial drugs in private and public settings.
Richard Tren | 06 Jun 2008 | New York Times
AFM Director Richard Tren writes in the New York Times, "Malaria control requires more than just nets. An associated danger with the grass-roots efforts is that simple but effective marketing messages conceal the fact that the disease is very complex and difficult to control. Along with nets, indoor spraying with insecticides is an essential, but poorly financed, method of malaria control. Improving access to high-quality malaria medicines is crucial, especially with the prospect of drug resistance ever present." This is the goal of the March of Washingtons - raising awareness of and funding for access to good quality malaria drugs.
Carlos Odora | 21 May 2008 | New Vision
Although malaria is preventable and curable, it is reported to claim 320 lives daily in Uganda. Recently, however, efforts to reduce these deaths have improved with more widespread use of insecticide-treated nets, indoor spraying with insecticides and better access to effective new Artemisinin combination medicine. Many people still access medicines from private pharmacies and shops.
Jasson Urbach | 16 May 2008 | Sowetan
Jasson Urbach reports on AFM's recently released study: Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa - A Six Country Study in South Africa's newspaper the Sowetan.
Roger Bate | 16 May 2008 | Globe and Mail
New field research shows that a third of anti-malaria drugs collected in six African cities fail at least one quality test, and aid agencies continue to fund untested, substandard drugs. The World Health Organization suggests that one-fifth of the approximately one million children who die every year from malaria die because of substandard and poorly prescribed medicines.
None | 15 May 2008 | Africa Fighting Malaria
It is with great saddness that we report the death on May 14 2008 of Professor Chris Curtis of the London School of Hygiene and Tropical Medicine. Prof. Curtis was a medical entomologist and a great malaria scientist whose field and laboratory research advanced malaria control greatly.
Richard Tren | 28 Apr 2008 | The Cutting Edge
April 25th marked World Malaria Day---an occasion to assess progress,
galvanize support, and of course, solemnly recognize the suffering that
this devastating disease causes.
None | 21 Apr 2008 | Africa Fighting Malaria
Indoor Residual Spraying (IRS) is a highly effective method of malaria control recommended by the World Health Organization. Unfortunately it remains underutilized in sub-Saharan Africa, where, each year, malaria kills over a million people and drains the continent of US$12 billion. World Malaria Day 2008 focuses on malaria across borders - some of the best cross-border malaria control programs rely heavily on IRS. Yet most donor agencies are loath to strengthen IRS programs in Africa, train medical entomologists to run them, and invest in new insecticides.